COVID-19 群体免疫：我们在哪里？
COVID-19 herd immunity: where are we?
机构信息
Emerging disease epidemiology unit, Institut Pasteur, Paris, France.
PACRI unit, Conservatoire National des Arts et Métiers, Paris, France.
出版信息
Nat Rev Immunol. 2020 Oct;20(10):583-584. doi: 10.1038/s41577-020-00451-5.
Abstract
Herd immunity is a key concept for epidemic control. It states that only a proportion of a population needs to be immune (through overcoming natural infection or through vaccination) to an infectious agent for it to stop generating large outbreaks. A key question in the current COVID-19 pandemic is how and when herd immunity can be achieved and at what cost.
摘要
群体免疫是控制传染病的一个关键概念。它指出，对于一种传染病，只有一部分人群（通过自然感染或接种疫苗获得免疫力）需要具有免疫力，才能阻止其引发大规模疫情。当前 COVID-19 大流行中的一个关键问题是如何以及何时可以实现群体免疫，以及需要付出什么代价。
相似文献
1
COVID-19 herd immunity: where are we?
Nat Rev Immunol. 2020 Oct;20(10):583-584. doi: 10.1038/s41577-020-00451-5.
2
Not just antibodies: B cells and T cells mediate immunity to COVID-19.
Nat Rev Immunol. 2020 Oct;20(10):581-582. doi: 10.1038/s41577-020-00436-4.
3
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
Vaccine. 2020 Nov 10;38(48):7588-7595. doi: 10.1016/j.vaccine.2020.10.034. Epub 2020 Oct 13.
4
Cross-reactive memory T cells and herd immunity to SARS-CoV-2.
Nat Rev Immunol. 2020 Nov;20(11):709-713. doi: 10.1038/s41577-020-00460-4. Epub 2020 Oct 6.
5
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Immunity. 2020 Oct 13;53(4):724-732.e7. doi: 10.1016/j.immuni.2020.07.019. Epub 2020 Jul 30.
6
Keeping track of the SARS-CoV-2 vaccine pipeline.
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
7
Whither COVID-19 vaccines?
Nat Biotechnol. 2020 Oct;38(10):1132-1145. doi: 10.1038/s41587-020-0697-7.
8
Coronavirus reinfections: three questions scientists are asking.
Nature. 2020 Sep;585(7824):168-169. doi: 10.1038/d41586-020-02506-y.
9
Advances in skin science enable the development of a COVID-19 vaccine.
J Am Acad Dermatol. 2020 Oct;83(4):1226-1227. doi: 10.1016/j.jaad.2020.05.126. Epub 2020 May 30.
10
The false promise of herd immunity for COVID-19.
Nature. 2020 Nov;587(7832):26-28. doi: 10.1038/d41586-020-02948-4.
引用本文的文献
1
Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study.
Cancers (Basel). 2025 Jun 11;17(12):1948. doi: 10.3390/cancers17121948.
2
Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia.
BMC Infect Dis. 2025 May 23;25(1):738. doi: 10.1186/s12879-025-11107-x.
3
Healthcare professionals' perceptions of system preparedness during public health emergencies: a path analysis of mental health impacts.
Front Public Health. 2025 Apr 17;13:1449207. doi: 10.3389/fpubh.2025.1449207. eCollection 2025.
4
A State-of-the-Science Review of Long-Term Predictions of Climate Change Impacts on Dengue Transmission Risk.
Environ Health Perspect. 2025 May;133(5):56002. doi: 10.1289/EHP14463. Epub 2025 May 16.
5
Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican Republic.
Sci Rep. 2025 Apr 2;15(1):11203. doi: 10.1038/s41598-025-94653-3.
6
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus.
Sci Adv. 2025 Jan 31;11(5):eadq4545. doi: 10.1126/sciadv.adq4545. Epub 2025 Jan 29.
7
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of US Children.
Open Forum Infect Dis. 2025 Jan 10;12(1):ofae680. doi: 10.1093/ofid/ofae680. eCollection 2025 Jan.
8
[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla].
Rev Med Inst Mex Seguro Soc. 2024 Sep 2;62(5):1-6. doi: 10.5281/zenodo.12667969.
9
Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage.
Viruses. 2024 Sep 26;16(10):1524. doi: 10.3390/v16101524.
10
Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in Europe.
Commun Med (Lond). 2024 Sep 11;4(1):178. doi: 10.1038/s43856-024-00600-0.
本文引用的文献
1
Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts.
medRxiv. 2020 Sep 11:2020.09.10.20192187. doi: 10.1101/2020.09.10.20192187.
Zotero 插件